PDS Biotechnology Corporation logo

PDS Biotechnology Corporation (PDSB) Q4 2024 Annual Earnings

PDSB·Reported March 27, 2025·Before market open

Diluted EPS came in at $-0.21, beat the $-0.29 consensus by $0.08.

Diluted EPS
$-0.21beat by $0.08
Consensus: $-0.29
SEC

SEC Filings

Earnings release8-K not filed yet
Annual report10-K · 0001140361-25-010717

Financial Snapshot

Trailing eight quarters through Q4 2024

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q4 2024 Earnings FAQ

Common questions about PDS Biotechnology Corporation's Q4 2024 earnings report.

PDS Biotechnology Corporation (PDSB) reported Q4 2024 earnings on March 27, 2025 before market open.

PDS Biotechnology Corporation reported diluted EPS of $-0.21 for Q4 2024.

EPS beat the consensus estimate of $-0.29 by $0.08.

You can read the 10-K periodic report (0001140361-25-010717) directly on SEC EDGAR. The filing index links above go to sec.gov.